US Map / Nevada
State NV

Clinical Trials in Nevada

Recruiting clinical trials with at least one study location in Nevada. Data updated daily from ClinicalTrials.gov.

Total Trials
86
Recruiting Now
86
← Back to US Map
Top Conditions in Nevada
Breast Cancer (5)Chronic Lymphocytic Leukemia (3)Hypertension (3)Asthma (2)Uncontrolled Hypertension (2)Small Lymphocytic Lymphoma (2)Schizophrenia (2)Geographic Atrophy (2)Acupuncture (2)Parkinson Disease (2)Non-small Cell Lung Cancer (1)Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (1)

Frequently Asked Questions — Clinical Trials in Nevada

How many clinical trials are currently recruiting in Nevada?
ClinicalMetric currently tracks 86 actively recruiting clinical trials with at least one location in Nevada. The total number of registered studies—including active but not currently enrolling trials—is 86. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Nevada?
Nevada hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Chronic Lymphocytic Leukemia, Hypertension, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Nevada serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Nevada?
To join a clinical trial in Nevada, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Nevada maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Nevada

NCT06561386 Phase 3
Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs...
Condition
Non-small Cell Lung Cancer
Enrollment
1,000 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06532279 Phase 2
Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the ...
Condition
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
98 pts
Location
United States
Sponsor
NRG Oncology
View Trial →
NCT06433752 N/A
Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMV...
Condition
Relapsing Multiple Sclerosis
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
TG Therapeutics, Inc.
View Trial →
NCT07220460 Phase 2
Recruiting
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With D...
Condition
Bipolar I or II Disorder
Enrollment
200 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
View Trial →
NCT05828069 Phase 2
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapse...
Condition
Recurrent Langerhans Cell Histiocytosis
Enrollment
48 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06143956 Phase 2
Recruiting
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices ...
Condition
Obesity
Enrollment
1,217 pts
Location
United States, Argentina
Sponsor
Eli Lilly and Company
View Trial →
NCT07015697 Phase 1
Recruiting
A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic S...
Condition
Recurrent or Metastatic Solid Tumors
Enrollment
76 pts
Location
United States, France, Japan
Sponsor
Daiichi Sankyo
View Trial →
NCT06993610 Phase 2
Recruiting
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Condition
Hidradenitis Suppurativa (HS)
Enrollment
225 pts
Location
United States, Canada, Germany
Sponsor
Zura Bio Inc
View Trial →
NCT06701682 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilob...
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
200 pts
Location
United States
Sponsor
PPD Development, LP
View Trial →
NCT07219173 Phase 2
Recruiting
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With...
Condition
Asthma
Enrollment
531 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
View Trial →
NCT07142356 Phase 2
Recruiting
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Condition
Uncontrolled Hypertension
Enrollment
280 pts
Location
United States
Sponsor
Retension Pharmaceuticals. Inc
View Trial →
NCT06012240 Phase 3
Recruiting
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adul...
Condition
Alopecia Areata
Enrollment
1,500 pts
Location
United States, Argentina, Australia
Sponsor
AbbVie
View Trial →
NCT04269902 Phase 3
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia...
Condition
Chronic Lymphocytic Leukemia
Enrollment
247 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05304767 Phase 3
Recruiting
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive Kar...
Condition
Schizophrenia
Enrollment
280 pts
Location
United States, Bulgaria, Czechia
Sponsor
Karuna Therapeutics, Inc., a B
View Trial →
NCT07000357 Phase 3
Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a Histo...
Condition
Cardiovascular Disease
Enrollment
15,100 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
View Trial →
NCT06052267 Phase 3
Recruiting
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol ...
Condition
Asthma
Enrollment
2,700 pts
Location
United States, Argentina, Australia
Sponsor
Teva Branded Pharmaceutical Pr
View Trial →
NCT06455475 N/A
Recruiting
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care...
Condition
Diabetic Foot Ulcer
Enrollment
150 pts
Location
United States
Sponsor
Capsicure, LLC
View Trial →
NCT06496620 Phase 2
Recruiting
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Condition
COPD
Enrollment
171 pts
Location
United States, Australia, Canada
Sponsor
Uniquity One (UNI)
View Trial →
NCT05797610 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Partici...
Condition
Primary IgA Nephropathy
Enrollment
428 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
View Trial →
NCT05281471 Phase 3
Recruiting
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Phy...
Condition
Platinum-resistant Ovarian Cancer
Enrollment
186 pts
Location
United States
Sponsor
Genelux Corporation
View Trial →
NCT05626114 Phase 2
Recruiting
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Acti...
Condition
Geographic Atrophy
Enrollment
60 pts
Location
United States, Israel
Sponsor
Genentech, Inc.
View Trial →
NCT07415044 Phase 2
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Condition
Ulcerative Colitis (UC)
Enrollment
1,431 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
View Trial →
NCT06500702 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzab...
Condition
Focal Segmental Glomerulosclerosis
Enrollment
84 pts
Location
United States, Argentina, Australia
Sponsor
Sanofi
View Trial →
NCT07298395 Phase 2
Recruiting
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Condition
Atopic Dermatitis (AD)
Enrollment
60 pts
Location
United States
Sponsor
Enveda Therapeutics
View Trial →
NCT05894239 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Ph...
Condition
Metastatic Breast Cancer
Enrollment
230 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
View Trial →
Page 1 of 4 — 86 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology